4,159 Shares in Aflac Incorporated (NYSE:AFL) Bought by PKS Advisory Services LLC

PKS Advisory Services LLC purchased a new stake in shares of Aflac Incorporated (NYSE:AFL) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 4,159 shares of the financial services provider’s stock, valued at approximately $430,000.

Several other hedge funds have also recently added to or reduced their stakes in AFL. Whipplewood Advisors LLC bought a new stake in Aflac in the 4th quarter worth approximately $26,000. BankPlus Trust Department bought a new stake in shares of Aflac in the 4th quarter worth approximately $34,000. Curio Wealth LLC purchased a new stake in shares of Aflac in the 4th quarter valued at $36,000. Raelipskie Partnership bought a new position in shares of Aflac during the 3rd quarter valued at $38,000. Finally, OFI Invest Asset Management bought a new stake in Aflac in the fourth quarter worth $38,000. Institutional investors own 67.44% of the company’s stock.

Insider Buying and Selling

In other news, Director Charles D. Lake II sold 29,802 shares of Aflac stock in a transaction that occurred on Monday, March 10th. The shares were sold at an average price of $107.29, for a total transaction of $3,197,456.58. Following the completion of the transaction, the director now directly owns 49,962 shares in the company, valued at approximately $5,360,422.98. This trade represents a 37.36 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Audrey B. Tillman sold 24,744 shares of the company’s stock in a transaction that occurred on Friday, December 27th. The stock was sold at an average price of $103.40, for a total value of $2,558,529.60. Following the completion of the sale, the executive vice president now owns 222,618 shares in the company, valued at $23,018,701.20. The trade was a 10.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 55,546 shares of company stock valued at $5,863,616 over the last ninety days. Company insiders own 0.90% of the company’s stock.

Analyst Ratings Changes

AFL has been the topic of a number of recent research reports. Evercore ISI reduced their price objective on Aflac from $104.00 to $102.00 and set an “underperform” rating on the stock in a research note on Wednesday, December 4th. JPMorgan Chase & Co. raised their price target on Aflac from $90.00 to $94.00 and gave the stock a “neutral” rating in a research report on Tuesday, January 7th. Keefe, Bruyette & Woods lowered their price objective on Aflac from $107.00 to $104.00 and set a “market perform” rating for the company in a research report on Wednesday, February 12th. BMO Capital Markets started coverage on shares of Aflac in a report on Thursday, January 23rd. They issued a “market perform” rating and a $111.00 target price on the stock. Finally, Morgan Stanley lifted their target price on shares of Aflac from $98.00 to $105.00 and gave the stock an “equal weight” rating in a research note on Friday, February 28th. Two analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have given a buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $103.36.

Aflac Trading Down 0.1 %

NYSE:AFL opened at $109.56 on Wednesday. Aflac Incorporated has a 12 month low of $79.31 and a 12 month high of $115.50. The company has a current ratio of 0.10, a quick ratio of 0.08 and a debt-to-equity ratio of 0.29. The company has a 50-day moving average price of $106.21 and a 200-day moving average price of $107.62. The stock has a market cap of $59.88 billion, a price-to-earnings ratio of 11.41, a P/E/G ratio of 3.24 and a beta of 0.93.

Aflac (NYSE:AFL) last posted its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. Equities analysts predict that Aflac Incorporated will post 6.88 EPS for the current year.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.